Finally, diclofenac, another COX-2 inhibitor, decreased tumor vascularization by downregulating VEGF abundance in the TME, leading to a reduction of 60% of the tumor mass in a mouse model of pancreatic cancer [222]. The gene discussed is PTGS2; the disease is neoplasm.